CN1236782C - 一种低毒性的鸦胆子油乳注射液及制备方法 - Google Patents
一种低毒性的鸦胆子油乳注射液及制备方法 Download PDFInfo
- Publication number
- CN1236782C CN1236782C CN 03156023 CN03156023A CN1236782C CN 1236782 C CN1236782 C CN 1236782C CN 03156023 CN03156023 CN 03156023 CN 03156023 A CN03156023 A CN 03156023A CN 1236782 C CN1236782 C CN 1236782C
- Authority
- CN
- China
- Prior art keywords
- injection
- fructus bruceae
- oleum fructus
- water
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000839 emulsion Substances 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title claims abstract description 20
- 241001533159 Brucea javanica Species 0.000 title abstract description 19
- 235000010889 Rhus javanica Nutrition 0.000 title abstract description 19
- 231100000053 low toxicity Toxicity 0.000 title abstract 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 78
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 46
- 238000002347 injection Methods 0.000 claims abstract description 37
- 239000007924 injection Substances 0.000 claims abstract description 37
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 35
- 239000000787 lecithin Substances 0.000 claims abstract description 35
- 229940067606 lecithin Drugs 0.000 claims abstract description 35
- 235000010445 lecithin Nutrition 0.000 claims abstract description 35
- 239000000203 mixture Substances 0.000 claims abstract description 24
- 239000009969 fructus bruceae Substances 0.000 claims description 63
- 238000007670 refining Methods 0.000 claims description 31
- 210000000481 breast Anatomy 0.000 claims description 24
- 239000008215 water for injection Substances 0.000 claims description 23
- 238000010438 heat treatment Methods 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 238000004945 emulsification Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 abstract description 10
- 238000012360 testing method Methods 0.000 abstract description 9
- 239000002245 particle Substances 0.000 abstract description 5
- 230000001954 sterilising effect Effects 0.000 abstract description 3
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 3
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 230000032798 delamination Effects 0.000 abstract 1
- 238000005538 encapsulation Methods 0.000 abstract 1
- 238000005070 sampling Methods 0.000 abstract 1
- 239000000945 filler Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 235000013399 edible fruits Nutrition 0.000 description 9
- 238000002156 mixing Methods 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 6
- 231100000419 toxicity Toxicity 0.000 description 6
- 230000001988 toxicity Effects 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 4
- 210000003022 colostrum Anatomy 0.000 description 4
- 235000021277 colostrum Nutrition 0.000 description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 231100000682 maximum tolerated dose Toxicity 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 206010003445 Ascites Diseases 0.000 description 2
- 206010011703 Cyanosis Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000003475 lamination Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 101710183280 Topoisomerase Proteins 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
现有技术 | 本发明技术 | |
生产方法 | 取精制豆磷脂与温热的甘油与适量的注射用水混合,转入到高速组织捣碎机内(8000转/分)搅拌二次,第一次5分钟,第二次2分钟,使其分散均匀,加入温热的鸦胆子油,搅拌3次,每次2分钟,使成初乳剂,加入注射用水至1000ml,再转入到高压乳匀机内(40Mpa)匀化三次,滤过,取滤液,灌封,灭菌,即得。 | 取精制鸦胆子油倒入搅拌罐内加热至60-90℃,然后加入豆磷脂,剪切混合均匀。将注射用水加入高压均质循环罐中,再加入甘油,加热至75℃混合,开启均质机,缓缓加入已剪切混合均匀的精制鸦胆子油与豆磷脂的混合物,调节高压均质机压力,使低压10-30Mpa,高压30-50Mpa,连续循环3-6遍,取样检验,灌封灭菌,即得。 |
产品质量 | 乳剂乳粒直径大,大多在5μm以上,甚至达到15μm,毒性大,不稳定。 | 乳粒更均匀细腻,安全稳定。直径可达1μm,且95%的乳粒直径小于0.4μm,最大颗粒不超过5μm。 |
急性毒性* | LD50为6.25g/kg。 | 静脉给药243g/kg(最大耐受量)未见动物死亡。 |
临床不良反应** | 小部分患者有较强的心血管系统和呼吸系统反应,严重者出现心率和呼吸加快,紫绀等;有临床死亡病例报道。 | 经647例临床研究,未见有不良反应发生。 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03156023 CN1236782C (zh) | 2003-08-28 | 2003-08-28 | 一种低毒性的鸦胆子油乳注射液及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03156023 CN1236782C (zh) | 2003-08-28 | 2003-08-28 | 一种低毒性的鸦胆子油乳注射液及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1488395A CN1488395A (zh) | 2004-04-14 |
CN1236782C true CN1236782C (zh) | 2006-01-18 |
Family
ID=34156869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 03156023 Ceased CN1236782C (zh) | 2003-08-28 | 2003-08-28 | 一种低毒性的鸦胆子油乳注射液及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1236782C (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101683367B (zh) * | 2006-08-22 | 2011-07-20 | 浙江九旭药业有限公司 | 含鸦胆子油的乳化药物组合物的制备方法 |
CN101804085B (zh) * | 2010-05-06 | 2011-04-20 | 沈阳药大药业有限责任公司 | 鸦胆子油和含鸦胆子油的药物组合物及制备方法 |
CN102133245B (zh) * | 2011-03-16 | 2013-01-09 | 沈阳药大药业有限责任公司 | 降低蛋白质含量的鸦胆子油及其药物组合物以及它们的制备方法 |
CN108853160B (zh) * | 2017-05-08 | 2021-10-22 | 沈阳药大雷允上药业有限责任公司 | 鸦胆子油、含鸦胆子油的药物组合物及其制备方法 |
CN112972374B (zh) * | 2019-12-16 | 2022-11-04 | 沈阳药大雷允上药业有限责任公司 | 含鸦胆子油的乳剂的制备方法 |
-
2003
- 2003-08-28 CN CN 03156023 patent/CN1236782C/zh not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
CN1488395A (zh) | 2004-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1470255A (zh) | 自丹参三七中提取的制备物及其复方制备方法和医疗用途 | |
CN1236782C (zh) | 一种低毒性的鸦胆子油乳注射液及制备方法 | |
CN1285358C (zh) | 一种药物组合物及其制备方法和质量控制方法 | |
CN1686404A (zh) | 一种调节免疫的参芪组合物及其制备方法 | |
CN1781537A (zh) | 生脉注射制剂及其制备方法 | |
CN1254245C (zh) | 羟喜树碱乳剂及其制备方法 | |
CN1720948A (zh) | 红茴香滴丸及其制备方法 | |
CN1698717A (zh) | 一种中药复方脂肪乳注射液及其制备方法 | |
CN101028437A (zh) | 一种防治心脑血管疾病的中药有效部位组合物及制备方法 | |
CN1990032A (zh) | 灵芝孢子油与薏苡仁油复合静脉注射乳剂及其制备方法 | |
CN1217675C (zh) | 治疗更年期综合症的药物及其制造方法 | |
CN1471908A (zh) | 倍半萜酮类注射剂及其制备方法和用途 | |
CN1140286C (zh) | 治疗冠心病的药物及其制备方法 | |
CN1682970A (zh) | 一种苦碟子注射制剂的制备方法 | |
CN1923223A (zh) | 一种纳米参芪扶正注射制剂的制备方法及其应用 | |
CN1850185A (zh) | 一种益气复脉、活血化瘀的益心舒注射制剂及其制备方法 | |
CN1205982C (zh) | 一种治疗心血管病症的香丹滴注液 | |
CN1265805C (zh) | 降血糖中药口服制剂及其制备方法 | |
CN1264500C (zh) | 治疗肺心病及能量补充的脂肪乳输液及其生产方法 | |
CN1857255A (zh) | 一种注射用银杏内酯b乳剂 | |
CN1079396A (zh) | 增智药物制剂增智素 | |
CN1156287C (zh) | 一种治疗心肌疾病的药物组合物 | |
CN1742783A (zh) | 一种扶正益气天然药物制剂及其制备方法 | |
CN1895495A (zh) | 一种治疗胃病的猴头健胃灵软胶囊 | |
CN1275609C (zh) | 用于治疗心脑血管疾病的中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Zhu Deling Document name: Deemed not to advise |
|
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI RENXIN MEDICINE SCIENCE CO., LTD.; LI HO Free format text: FORMER OWNER: LI HONG; ZHU DELING; YU ZIXUN Effective date: 20070427 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20070427 Address after: 321016 Zhejiang city of Jinhua province Xian No. 398 North Street Co-patentee after: Li Hong Patentee after: Shanghai Ren Xin Pharmaceutical Technology Co., Ltd. Address before: 322200 No. 46, Stadium East Road, Pujiang County, Zhejiang Province Co-patentee before: Zhu Deling Patentee before: Li Hong Co-patentee before: Yu Zixun |
|
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Yue Changlin Document name: Notice of conformity |
|
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Zhejiang Jiuxu Pharmaceutical Co., Ltd. Assignor: Li Hong|Shanghai Ren Xin Pharmaceutical Technology Co., Ltd. Contract fulfillment period: 2008.9.1 to 2023.8.28 Contract record no.: 2008330000924 Denomination of invention: Java brucea oil-emulsion injecta with low-toxicity and preparing method thereof Granted publication date: 20060118 License type: Exclusive license Record date: 20081009 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.9.1 TO 2023.8.28; CHANGE OF CONTRACT Name of requester: ZHEJIANG PROVINCE JIUXU PHARMACEUTICAL CO., LTD. Effective date: 20081009 |
|
ASS | Succession or assignment of patent right |
Owner name: LI HONG Free format text: FORMER OWNER: SHANGHAI RENXIN PHARMA TECHNOLOGY CO., LTD. Effective date: 20101110 Owner name: SUINING RENXIN PHARMACEUTICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: LI HONG |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20101110 Address after: 321016 Zhejiang city of Jinhua province Xian No. 398 North Street Co-patentee after: Suining Ren Xin Pharmaceutical Technology Co., Ltd. Patentee after: Li Hong Address before: 321016 Zhejiang city of Jinhua province Xian No. 398 North Street Co-patentee before: Li Hong Patentee before: Shanghai Ren Xin Pharmaceutical Technology Co., Ltd. |
|
C35 | Partial or whole invalidation of patent or utility model | ||
IW01 | Full invalidation of patent right |
Decision date of declaring invalidation: 20130117 Decision number of declaring invalidation: 19904 Granted publication date: 20060118 |